Obesity is not only a well-known, significant risk factor for the development and progression of cardiovascular disease (CVD), but is also recognized as a disease entity in its own right and therefore also a comorbidity. Globally, there has been a rapid increase in prevalence over the last few decades, with more than one billion people affected by 2024. The obesity epidemic is a phenomenon that is being addressed by national and international cardiology societies in particular and discussed in corresponding consensus statements and guidelines.
Partner
Autoren
- Dr. med. Elisa Alba Schmidt
- PD Dr. med. David Niederseer
Publikation
- CARDIOVASC
Related Topics
You May Also Like
- Pathophysiological mechanisms and therapeutic perspectives
Metabolic syndrome in patients with schizophrenia
- Hand eczema: from diagnosis to treatment
Implementing sustainable, stage-appropriate measures
- Cystic fibrosis
Small spray – big footprint
- From symptom to diagnosis
Abdominal pain – Gastric outlet stenosis
- When the bones become more fragile: “Case Finding”
Fracture risk reduction in osteoporosis
- Biologics for plaque psoriasis
What increases the chance of a sustained remission?
- Findings from the ALS Symposium 2024 in Montreal
Current and future approaches in the treatment of amyotrophic lateral sclerosis (ALS)
- Pain and autism